Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Makoto Yoshihama is active.

Publication


Featured researches published by Makoto Yoshihama.


The Journal of Steroid Biochemistry and Molecular Biology | 1993

Aromatase activity and the effect of estradiol and testosterone on DNA synthesis in endometrial carcinoma cell lines

Akio Tada; Hiroshi Sasaki; Junji Nakamura; Makoto Yoshihama; Yoshiteru Terashima

Human endometrial and breast carcinoma cell lines were examined for aromatase activity and the effects of sex steroids (estradiol and testosterone) on DNA synthesis. Aromatase activity was high (greater than 500 fmol/10(7) cells/24 h) in the cell lines MCF-7 and OMC-2, moderate (100-499 fmol/10(7) cells/24 h) in the cell lines HEC-59 and Ishikawa, and low (less than 100 fmol/10(7) cells/24 h) in the HHUA cell line. A substantial stimulation of DNA synthesis by estradiol (10(-9)M) was observed in cell lines HEC-59, OMC-2, and MCF-7, with an increase in [3H]thymidine uptake of over 250%. The Ishikawa cell line was stimulated moderately (115-249%). No estradiol-induced increase in DNA synthesis was observed in HHUA. Responsiveness of DNA synthesis to testosterone was observed in cell lines that showed the greatest response to estradiol, namely HEC-59, OMC-2, and MCF-7. Otherwise, estrogen-responsiveness did not always correlated with a significant aromatase activity. These data suggest that some but not all endometrial carcinomas may possess an aromatase-dependent growth stimulating system.


Journal of Fermentation and Bioengineering | 1989

Microbial production of two new dihydroxylated androstenedione derivatives by acremonium strictum

Makoto Yoshihama; Masamichi Nakakoshi; Kohji Tamura; Nobuo Miyata; Gosei Kawanishi; Mitsugi Iida

Abstract We found that Acremonium strictum NN106 converted 4-androstene-3, 17-dione (androstenedione) to 12 compounds. Among them, five products were isolated and found to be hydroxylated at the 11α-, 14α-, 7α, 11α-, 6β, 11α- or 6β, 14α-positions of androstenedione. 6β, 11α-Dihydroxy and 6β, 14α-dihydroxy derivatives of androstenedione have been obtained for the first time. From the time course profile of this transformation, sequential hydroxylation at the 6β-position followed by 11α- or 14α-monohydroxylation was observed. The oxidative product of the 6β, 14α-dihydroxy derivative was found to be the most potent inhibitor of human placentral aromatase.


Journal of Fermentation and Bioengineering | 1989

Microbial Polyhydroxylation of Progesterone by Acremonium strictum

Makoto Yoshihama; Masamichi Nakakoshi; Kohji Tamura; Nobuo Miyata; Gosei Kawanishi; Mitsugi Iida

Abstract Acremonium strictum NN106, which has been shown to have a unique hydroxylating ability on androstenedione, also transformed progesterone into a mixture of various products. Six products were isolated in sufficient amounts for structural analysis. Three products were found to have two hydroxy moieties on axial and equatorial positions at 7β, 15β-, 6β, 11α- and 11α, 15β-sites. The other three products had an extra 17α-hydroxyl on the above dihydroxy derivatives to give trihydroxy progesterone. This type of microbial polyhydroxylation of a steroid caused by a fungal strain has not been reported so far and 7β, 15β, 17α-trihydroxy-4-pregnene-3,20-dione is a hitherto unknown compound which was obtained for the first time in the course of this experiment. The 6β, 11α-dihydroxylation has been found in the transformation of androstenedione, but the other positions of hydroxyl introduction are different. The hydroxylating events caused by this strain were greatly influenced by the 17β side chain, especially by C20 keto moiety in the steroidal skeleton.


Journal of Fermentation and Bioengineering | 1995

Microbial production of hydroxy-C19-steroids as estrogen synthetase (P-450 · aromatase) inhibitors

Shigeru Mineki; Mitsugi Iida; Katsuya Kato; Fuyuki Fukaya; Kazuhiro Kita; Junji Nakamura; Makoto Yoshihama

Abstract Four monohydroxy derivatives of androst-4-ene-3,17-dione (4AD) and two of androst-4-ene-3,6,17-trione (4AT), derived from microbial transformation of 4AD and 4AT, were purified and identified by UV, IR, mass, 13 C-NMR, and 1 H-NMR spectroanalyses. These derivatives were evaluated as inhibitors of human placental aromatase. They showed dose-dependent inactivation of aromatase in the presence of reduced nicotinamide adenine dinucleotide phosphate. Among them, 6α-hydroxyandrost-4-ene-3,17-dione (6α-OH-4AD) was the most potent, exhibiting 97.8% inhibition at 100 μM; this value was 1.04-fold higher than the inhibition shown by 4AT (93.6%). The other derivatives, 16β-OH-4AT, 15α-OH-4AD, 15β-OH-4AD, 6β-OH-4AD and 12α-OH-4AT, inhibited the aromatase 80.4%, 63.6%, 61.8%, 30.1%, and 9.6%, respectively, at the same concentration.


Bioscience, Biotechnology, and Biochemistry | 2007

Inhibition of 17α-Hydroxylase/C17,20-Lyase (CYP17) from Rat Testis by Green Tea Catechins and Black Tea Theaflavins

Ken-ichi Kimura; Yoshie Itakura; Reika Goto; Masato Tojima; Nobumi Egawa; Makoto Yoshihama

In the course of screening for 17α-hydroxylase/C17,20-lyase inhibitors from food ingredients, the methanol soluble fraction of green tea and black tea, which were expected to be rich in catechin and theaflavin content, showed potent inhibitory activity. (−)-Epigallocathechin gallate and theaflavin 3-O-gallate with a pirogallol moiety significantly inhibited C17,20-lyase activity on IC50 values of 24.5 μM and 11.5 μM respectively. They had potent cytotoxicity against human prostate cancer LNCaP cells (IC50=28.1 μM and 37.4 μM).


The Journal of Antibiotics | 1998

Selective inhibition of the bacterial peptidoglycan biosynthesis by the new types of liposidomycins

Ken-ichi Kimura; Yoshikazu Ikeda; Shinobu Kagami; Makoto Yoshihama; Katsuhiro Suzuki; Kiyoshi Isono


The Journal of Clinical Endocrinology and Metabolism | 2001

The Analyses of 17β-Hydroxysteroid Dehydrogenase Isozymes in Human Endometrial Hyperplasia and Carcinoma1

Hiroki Utsunomiya; Takashi Suzuki; Chika Kaneko; Junji Takeyama; Junji Nakamura; Ken-ichi Kimura; Makoto Yoshihama; Nobuhiro Harada; Kiyoshi Ito; Ryo Konno; Shinji Sato; Kunihiro Okamura; Hironobu Sasano


The Journal of Antibiotics | 1997

Propeptin, a New Inhibitor of Prolyl Endopeptidase Produced by Microbispora I. Fermentation, Isolation and Biological Properties

Ken-ichi Kimura; Fumiko Kanou; Hidetoshi Takahashi; Yasuaki Esumi; Masakazu Uramoto; Makoto Yoshihama


The Journal of Antibiotics | 1992

Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities.

Hidetoshi Takahashi; Hiroyuki Koshino; Mutsumi Sasaki; Rie Onose; Masamichi Nakakoshi; Makoto Yoshihama; Kiyoshi Isono


The Journal of Clinical Endocrinology and Metabolism | 2000

17β-Hydroxysteroid Dehydrogenase Type 1 and 2 Expression in the Human Fetus1

Junji Takeyama; Takashi Suzuki; Gen Hirasawa; Yasunari Muramatsu; Hiroshi Nagura; Kazuie Iinuma; Junji Nakamura; Ken-ichi Kimura; Makoto Yoshihama; Nobuhiro Harada; Stefan Andersson; Hironobu Sasano

Collaboration


Dive into the Makoto Yoshihama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge